60% of US Women May Have Cardiovascular Disease by 2050, Driven by Blood Pressure Surge

The numbers are stark, and the trajectory is worsening. By 2050, projections suggest that nearly 6 in 10 women in the United States will be living with some form of cardiovascular disease - a forecast that has profound implications for health systems, public health policy, and the lives of millions of women across every age group.

The projections come from a scientific statement published in Circulation, the flagship journal of the American Heart Association, and represent an update to prior estimates that placed cardiovascular disease prevalence among US women at roughly 5 in 10 in 2020. The new statement, titled Forecasting the Burden of Cardiovascular Disease and Stroke in the United States Through 2050 in Women, finds that prevalence is expected to climb across every major cardiovascular condition, and that the economic cost of that burden will rise alongside it.

High Blood Pressure Is Driving the Trend

Among the contributing factors, hypertension stands out most clearly. The statement projects that close to 60% of US women will have high blood pressure by 2050, up from approximately 50% in earlier estimates for 2020. Hypertension is the single most common modifiable risk factor for heart disease, stroke, and heart failure, and its rising prevalence across women of all ages underlies much of the projected increase in overall cardiovascular disease burden.

Obesity and diabetes are expected to amplify those trends. Both conditions accelerate arterial damage, worsen blood pressure control, and increase the risk of atrial fibrillation and heart failure independently of other risk factors. The statement projects increases in obesity and diabetes prevalence among women that will compound hypertension's effects across the population.

"One in every three women will die from cardiovascular disease - maybe it's your grandmother, or your mother or your daughter," said Karen E. Joynt Maddox, M.D., M.P.H., volunteer chair of the writing group and professor of medicine and public health at Washington University School of Medicine in St. Louis. "More than 62 million women in the US are living with some type of cardiovascular disease and that comes with a price tag of at least $200 billion, annually. Our estimates indicate that if we stay on the current path, these numbers will grow substantially over the next 25 to 30 years."

Young Women and Girls Are Not Exempt

One of the most sobering findings in the statement concerns younger populations. The projections indicate that nearly 32% of women aged 22 to 44 will have some form of cardiovascular disease by 2050, compared to less than 1 in 4 currently. That represents a significant shift in the age profile of cardiovascular disease in women - a condition that has historically been framed as a problem for older adults.

Among girls aged 2 to 19, approximately 32% may have obesity by 2050. Childhood and adolescent obesity is a strong predictor of adult cardiovascular risk, and these projections suggest the next generation is entering adulthood with a heavier burden of risk than previous cohorts.

"We know the factors that contribute to heart disease and stroke begin early in life, even among young women and girls," said Stacey E. Rosen, M.D., volunteer president of the American Heart Association. "The impact is even greater among those experiencing adverse social determinants of health such as poverty, low literacy, rural residence and other psychosocial stressors."

Racial and Ethnic Disparities Widen

The statement documents particularly pronounced increases in cardiovascular disease prevalence among women identifying as American Indian or Alaska Native, Black, Hispanic, or multiracial. These populations already carry a disproportionate burden of hypertension, diabetes, and obesity, and the projections suggest those gaps will widen without targeted intervention.

Access to preventive care, insurance coverage, geographic proximity to health services, and exposure to chronic stress associated with systemic inequality all contribute to differential cardiovascular risk. The statement identifies these structural factors as central to understanding why projections for some demographic groups are substantially worse than population averages.

Economic Costs Measured in Hundreds of Billions

The current annual economic burden of cardiovascular disease in women exceeds $200 billion in the United States. That figure encompasses direct health care costs - hospitalizations, medications, procedures - and indirect costs including lost productivity and disability. As prevalence rises over the next 25 years, that figure is projected to climb in ways that will place significant strain on both public and private health financing.

The statement notes that prevention represents the most cost-effective path forward. Managing hypertension through lifestyle intervention and medication remains far cheaper than treating its downstream consequences - strokes, heart attacks, and heart failure - and the cumulative benefit of earlier intervention compounds over decades.

Limitations of Long-Range Projection

Any 25-year forecast carries uncertainty. The projections in this statement are built on current trends in risk factor prevalence and assume those trends continue without major policy or behavioral shifts. They cannot account for new treatments, changes in smoking or physical activity rates, or the potential effects of anti-obesity medications that have recently transformed type 2 diabetes management. The projections also rely on self-reported data in some components and national survey data that may not fully capture the most marginalized populations.

These are projections, not predictions - they represent what will likely happen if current trajectories hold, which is precisely the point. The statement is as much a call for course correction as a forecast.

Cardiovascular disease has long been mischaracterized as a predominantly male problem. The data in this statement make clear that it is the leading cause of death for women in the United States and that without substantive changes in prevention, detection, and treatment, that burden will grow considerably heavier in the decades ahead.